Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
LavaMed is a China based medical devices manufacturing company.
Lupeng Pharmaceutical is a biotech company that focuses on the drug discovery and development of novel therapies for cancer treatment.
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.
Virtue Diagnostics is an innovative IVD company focused on infectious disease, cancer, and chronic diseases.
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Singleron Biotechnologies is an innovative molecular diagnostic company.
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Scivita Medical Technology is focusing on the image processing R&D and technology innovation of endoscope.
Zentera Therapeutics is a biopharmaceutical company.
Duality Biologics is a company focusing on the discovery, development and commercialization of new modality biologics to provide solutions.
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies
EdiGene is a biotechnology company that develops genome editing technologies.
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.
NovoCodex is a biopharmaceuticals company that specalizes in the business of genetic engineering, and cell culture.
FutureGen is a research and development manufacturer for antibody medication.
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Leader in true multi-omic spatial sequencing
Peijia Medical is an interventional medical products provider
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.
Lilly Asia Ventures has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lilly Asia Ventures's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 17 different industry categories.
Among tracked funding rounds, Turning Point Therapeutics received $460.0M in a Post Ipo Equity round. Lilly Asia Ventures's total known invested capital is $8.3B.
Lilly Asia Ventures's average investment size is $103.5M across its portfolio of 102 companies.
Recent Lilly Asia Ventures portfolio additions include LavaMed, Lupeng Pharmaceutical, Neukio Biotherapeutics, Singlera Genomics, Virtue Diagnostics. These companies were founded in 2020 or later.